Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LORENA LEWY-ALTERBAUM

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1184789943
CMS profile
9002
Location
HOLLYWOOD, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$1,788.44

82 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,788.44 82

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LORENA LEWY-ALTERBAUM

NPI 1184789943 · CMS profile ID 9002

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

HOLLYWOOD, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1184789943?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LORENA LEWY-ALTERBAUM, NPI 1184789943, CMS profile ID 9002. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1184789943?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). LORENA LEWY-ALTERBAUM, NPI 1184789943, CMS profile ID 9002. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1184789943?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
LORENA LEWY-ALTERBAUM, NPI 1184789943, CMS profile ID 9002, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1184789943?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

82 matching records · $1,788.44 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 82 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–82 of 82.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Medtronic, Inc. $16.6505/08/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247157528 CMS
Novo Nordisk Inc $19.9005/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096985267 CMS
Amneal Pharmaceuticals LLC $19.2804/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139193146 CMS
Lilly USA, LLC $23.2404/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135157503 CMS
Novo Nordisk Inc $23.9604/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097239867 CMS
Tandem Diabetes Care, Inc. $31.3804/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138743605 CMS
Tandem Diabetes Care, Inc. $23.1604/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138747323 CMS
Lilly USA, LLC $25.3204/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135157501 CMS
Medtronic, Inc. $19.1004/15/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247157530 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.4304/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117908192 CMS
Novo Nordisk Inc $19.8204/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097791631 CMS
Lilly USA, LLC $17.8404/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135140166 CMS
Novartis Pharmaceuticals Corporation $16.8303/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087081196 CMS
Novo Nordisk Inc $24.9503/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097517294 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.5003/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117908194 CMS
ABBVIE INC. $13.0803/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104171246 CMS
Abbott Laboratories $20.5303/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124889125 CMS
Amneal Pharmaceuticals LLC $20.6803/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139193144 CMS
Medtronic, Inc. $27.1403/05/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247157526 CMS
Lilly USA, LLC $16.1402/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135156261 CMS
SANOFI-AVENTIS U.S. LLC $21.4302/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139594138 CMS
Dexcom, Inc. $24.5002/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153317386 CMS
Insulet Corporation $44.0902/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116797365 CMS
Lilly USA, LLC $21.1702/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135093877 CMS
Lilly USA, LLC $29.5502/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135093873 CMS
Lilly USA, LLC $31.2302/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135158871 CMS
Novo Nordisk Inc $21.1402/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097821428 CMS
Amneal Pharmaceuticals LLC $15.5002/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139193142 CMS
Novo Nordisk Inc $13.2701/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096901681 CMS
Lilly USA, LLC $13.4801/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135093875 CMS
Novo Nordisk Inc $18.2801/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097770946 CMS
Insulet Corporation $28.4001/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116797385 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,557.00 73
PY2020 $2,722.73 76
PY2021 $1,712.80 106
PY2022 $953.04 68
PY2023 $1,612.15 83
PY2024 $1,788.44 82
PY2025 $14,598.83 118

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $519,675.16 25
PY2024 Principal investigator $319,784.19 96
PY2023 Recipient $198.36 1
PY2023 Principal investigator $214,700.71 13
PY2022 Recipient $298.00 1
PY2022 Principal investigator $287,695.66 62
PY2021 Principal investigator $434,350.94 83
PY2020 Recipient $1,993.90 3
PY2020 Principal investigator $262,620.98 97
PY2019 Recipient $10,617.99 3
PY2019 Principal investigator $1,058,330.17 97

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,520.00 12/31/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH
A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism No dispute reported 06/30/2026 1202532384
Principal investigator 1 ABBVIE INC. $13,766.25 11/05/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202522551
Principal investigator 1 ABBVIE INC. $4,131.25 10/09/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202515755
Principal investigator 1 Novartis Pharmaceuticals Corporation $46,947.91 10/08/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH
A randomized, double-blind, placebo-controlled, multicenter, dose range finding study, to evaluate efficacy, safety and pharmacodynamics of QCZ484 in mild to moderate hypertensive patients No dispute reported 06/30/2026 1190304329
Principal investigator 1 ABBVIE INC. $11,670.00 09/04/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202508590
Principal investigator 1 ABBVIE INC. $10,411.25 08/06/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202502558
Principal investigator 1 Eli Lilly and Company $239,073.58 07/07/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A PHASE 3B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE RETATRUTIDE TREATMENT IN THE MAINTENANCE OF WEIGHT REDUCTION IN INDIVIDUALS WITH OBESITY No dispute reported 06/30/2026 1187875183
Principal investigator 1 ABBVIE INC. $6,957.50 07/02/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202494779
Principal investigator 1 ABBVIE INC. $15,993.75 06/03/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202488699
Principal investigator 1 ABBVIE INC. $91.63 05/30/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202487127
Principal investigator 1 ABBVIE INC. $43.93 05/30/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202487129
Principal investigator 1 ABBVIE INC. $46.98 05/30/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202487131
Principal investigator 1 ABBVIE INC. $95.86 05/29/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202486929
Principal investigator 1 ABBVIE INC. $103.87 05/28/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202486469
Principal investigator 1 ABBVIE INC. $54.93 05/28/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202486481
Principal investigator 1 ABBVIE INC. $104.82 05/28/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202486483
Principal investigator 1 ABBVIE INC. $54.97 05/14/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202484829
Principal investigator 1 ABBVIE INC. $55.86 05/14/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202484831
Principal investigator 1 ABBVIE INC. $11,037.50 05/07/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202483145
Principal investigator 1 Eli Lilly and Company $14,485.97 04/21/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A STUDY OF TIRZEPATIDE (LY3298176) IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES SWITCHING FROM DULAGLUTIDE (SURPASS-SWITCH) (SURPASS-SWITCH) No dispute reported 06/30/2026 1187880517
Principal investigator 1 ABBVIE INC. $7,306.25 04/03/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202473003
Principal investigator 1 ABBVIE INC. $6,793.75 03/07/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202460035
Principal investigator 1 ABBVIE INC. $6,506.25 02/06/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH LLC
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202449754
Principal investigator 1 AstraZeneca Pharmaceuticals LP $23,297.00 01/08/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH
A Randomized DoubleBlind Parallel Group Multi Center Phase III Study to Assess the Efficacy of Budesonide Glycopyrronium and Formoterol Fumarate MeterednDose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease THARROS No dispute reported 06/30/2026 1185550731
Principal investigator 1 AstraZeneca Pharmaceuticals LP $95,124.10 01/03/2025 Non-covered Recipient Entity
ALL MEDICAL RESEARCH
A Randomised Double-Blind Placebo-Controlled Parallel Group Study to Assess the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants with Resistant Hypertension No dispute reported 06/30/2026 1185550729